These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36706775)

  • 21. Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.
    Hsiang JC; Sinnaswami P; Lee MY; Zhang MM; Quek KE; Tan KH; Wong YM; Thurairajah PH
    Singapore Med J; 2022 Feb; 63(2):86-92. PubMed ID: 32729280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Luo R; Fong Y; Boeras D; Jani I; Vojnov L
    Lancet; 2022 Sep; 400(10356):887-895. PubMed ID: 36116479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain.
    Saludes V; Antuori A; Lazarus JV; Folch C; González-Gómez S; González N; Ibáñez N; Colom J; Matas L; Casabona J; Martró E
    Int J Drug Policy; 2020 Jun; 80():102734. PubMed ID: 32470849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison.
    Byrne CJ; Malaguti A; Inglis SK; Dillon JF
    BMJ Open; 2023 Apr; 13(4):e068604. PubMed ID: 37037621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.
    Ochodo EA; Guleid F; Deeks JJ; Mallett S
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013207. PubMed ID: 34383961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the potential cost-effectiveness of centralised versus point-of-care testing for hepatitis C virus in Pakistan: a model-based comparison.
    Babigumira JB; Karichu JK; Clark S; Cheng MM; Garrison LP; Maniecki MB; Hamid SS
    BMJ Open; 2023 May; 13(5):e066770. PubMed ID: 37142306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    Page-Shipp L; Lewis JJ; Velen K; Senoge S; Zishiri E; Popane F; Chihota VN; Clark D; Churchyard GJ; Charalambous S
    PLoS One; 2018; 13(3):e0192089. PubMed ID: 29499060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study.
    Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL;
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):514-520. PubMed ID: 28442271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.
    Hosseini-Hooshyar S; Hajarizadeh B; Bajis S; Law M; Janjua NZ; Fierer DS; Chromy D; Rockstroh JK; Martin TCS; Ingiliz P; Hung CC; Dore GJ; Martinello M; Matthews GV
    Lancet HIV; 2022 Jun; 9(6):e414-e427. PubMed ID: 35659336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark.
    Demant J; Krohn-Dehli L; Van der Veen J; Øvrehus A; Lazarus JV; Weis N
    Int J Drug Policy; 2023 Nov; 121():104185. PubMed ID: 37774576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal.
    Duchesne L; Hejblum G; Toure Kane NC; Njouom R; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K
    Int J Drug Policy; 2020 Jan; 75():102613. PubMed ID: 31786434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature.
    Coats JT; Dillon JF
    Int J Drug Policy; 2015 Nov; 26(11):1050-5. PubMed ID: 26118799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care viral load testing among adolescents and youth living with HIV in Haiti: a protocol for a randomised trial to evaluate implementation and effect.
    Reif LK; Belizaire ME; Seo G; Rouzier V; Severe P; Joseph JM; Joseph B; Apollon S; Abrams EJ; Arpadi SM; Elul B; Pape JW; McNairy ML; Fitzgerald DW; Kuhn L
    BMJ Open; 2020 Aug; 10(8):e036147. PubMed ID: 32868354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia.
    Thedja MD; Wibowo DP; El-Khobar KE; Ie SI; Turyadi ; Setiawan L; Murti IS; Muljono DH
    Am J Trop Med Hyg; 2021 May; 105(1):117-124. PubMed ID: 33999849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care With Standard Human Immunodeficiency Virus (HIV) Viral Load Monitoring in Nigeria.
    Chang C; Agbaji O; Mitruka K; Olatunde B; Sule H; Dajel T; Zee A; Ahmed ML; Ahmed I; Okonkwo P; Chaplin B; Kanki P
    Clin Infect Dis; 2023 Feb; 76(3):e681-e691. PubMed ID: 35867672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.